Amarin Supports Latest Clinical Research Evaluating VASCEPA® (Icosapent Ethyl) in Patients with Persistent Cardiovascular Risk Presented at ESC Congress 2020, the Annual Meeting of the European Society of Cardiology

NEXT STORY
Predictive Oncology Inc to Present at LD Micro’s “LD 500” Virtual Investor Conference on Wednesday, September 02, 2020 3:40 PM Eastern Time
PREV STORY
Sun BioPharma, Inc. Closes $10.5 Million Public Offering of Common Stock and Warrants
Subscribe now to PM360
Get in touch with PM360 Experts On Call

Experts on Call

Ads

You May Also Like

Antares Pharma Announces Submission of IND Application for ATRS-1902 for Adrenal Crisis Rescue

author_avatar
NASDAQ Market News

Orthopedic Implants Market Size to Reach US $64 Billion by 2026; Rising Number of Orthopedic Sports Injuries to Favor Growth

author_avatar
NASDAQ Market News

Amgen, Cytokinetics and Servier Announce Topline Results From GALACTIC-HF, a Phase 3 Trial of Omecamtiv Mecarbil in Patients With Heart Failure

author_avatar
NASDAQ Market News